Contact
Please use this form to send email to PR contact of this press release:
NST Doses First Patient in Phase 2b Clinical Study of Icosabutate in NASH (‘ICONA’)
TO:
Please use this form to send email to PR contact of this press release:
NST Doses First Patient in Phase 2b Clinical Study of Icosabutate in NASH (‘ICONA’)
TO: